Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis® from Brazil ANVISA.

Bonvadis® > News > Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis® from Brazil ANVISA.
  1. Date of occurrence of the event: 2025/03/25
  2. Company Name: Oneness Biotech Co., Ltd.
  3. Relationship with the Company (Please enter the Head office or Subsidiary): Head office
  4. Mutual shareholding: Not applicable
  5. Current development stage: 
    Oneness received the notification today from the agent that Bonvadis® Topical Cream has passed the Brazilian Good Manufacturing Practice (B-GMP) certification according to the Brazilian Official Announcement (DOU) issued by ANVISA.
  6. Action taken: None
  7. Any other matters that need to be specified: The Brazilian Good Manufacturing Practice (B-GMP) certification is a mandatory regulatory requirement for approving medical device certification in Brazil. With the B-GMP certification, Oneness is eligible to apply for medical device product registration in the Brazilian market.